v3.26.1
Unaudited Condensed Consolidated Statements of Changes of Shareholders’ Equity (Deficit)
Ordinary Shares
USD ($)
shares
Ordinary Shares
CNY (¥)
shares
Addition paid-in capital
USD ($)
Addition paid-in capital
CNY (¥)
Deferred stock compensation
USD ($)
Deferred stock compensation
CNY (¥)
Statutory Reserves
USD ($)
Statutory Reserves
CNY (¥)
Accumulated other comprehensive loss
USD ($)
Accumulated other comprehensive loss
CNY (¥)
Accumulated deficit
USD ($)
Accumulated deficit
CNY (¥)
USD ($)
CNY (¥)
Balance at Sep. 30, 2024   ¥ 7,272       ¥ 1,679,428   ¥ (656,670)   ¥ (8,218,211)   ¥ (7,188,181)
Balance (Shares) at Sep. 30, 2024 | shares 18,000,000 18,000,000                        
Net income (loss)             (4,233,119)   (4,233,119)
Foreign currency Translation           (324,888)     (324,888)
Balance at Mar. 31, 2025   ¥ 7,272       1,679,428   (981,558)   (12,451,330)   (11,746,188)
Balance (Shares) at Mar. 31, 2025 | shares 18,000,000 18,000,000                        
Balance at Sep. 30, 2025   ¥ 8,399   66,212,597     1,679,428   (1,611,000)   (21,047,417)   45,242,007
Balance (Shares) at Sep. 30, 2025 | shares 20,500,000 20,500,000                        
Private placement   ¥ 44,037   28,576,232           28,620,269
Private placement (Shares) | shares 100,567,000 100,567,000                        
Option granted     12,961,565   (12,961,565)        
Amortization of deferred stock compensation       1,440,174         1,440,174
Options exercised   ¥ 1,773             1,773
Options exercised (Shares) | shares 4,050,000 4,050,000                        
Net income (loss)             4,825,973 $ 699,620 4,825,973
Foreign currency Translation           (1,948,154)     (1,948,154)
Balance at Mar. 31, 2026 $ 7,859 ¥ 54,209 $ 15,620,527 ¥ 107,750,394 $ (1,670,251) ¥ (11,521,391) $ 243,466 ¥ 1,679,428 $ (515,969) ¥ (3,559,154) $ (2,351,616) ¥ (16,221,444) $ 11,334,016 ¥ 78,182,042
Balance (Shares) at Mar. 31, 2026 | shares 125,117,000 125,117,000